The @US_FDA has now authorized “pooled testing” for #COVID19 to save testing reagents and speed results. I’m a big fan. But, this only works in low prevalence situations. To see why, here is some fun Sunday morning math for you all.
Pooled testing works like this. You get individual swabs from a bunch of people, set aside some of the sample for each person in case needed later, and mix the rest together. Now test the mixed (pooled) sample. If negative, you’re done! One test for N people, saving N-1 tests.
If the pool is positive, you have to go retest each individual sample to identify the positive(s). Plus, you already did one extra test for the initial pooled sample. So a positive pool costs N+1 tests. You can see where we are going here...
The FDA has approved pooling for 4 samples at a time, so let’s set our N to 4 for the sake of example. Neg pool=1 test, pos pool=5 tests. Individual testing=4 tests. Clearly, the key is the ratio of positive to negative pools. The more positives, the fewer tests we save.
The probability of a positive pool is related to the underlying prevalence in the group being tested. That is, how many people in the group are likely to be positive? Right now, national positive test rate is 7.4%. Let’s start with that. coronavirus.jhu.edu/testing/indivi…
The negative test rate is the inverse, or 92.6%. Prob that all 4 tests are negative is 0.926^4=0.735. So on average, 73.5% of pools will be negative, and 26.5% will have at least one positive. Call it 74&26. If we do 100 pools of 4, we will need 74+(26*5) tests=204 tests.
Bonanza! If we had done all those individually, we would have needed 400 tests. We have saved 196 tests - or put another way, we have boosted our test capacity by 50%! BUT suppose we are in Arizona, where current test positive rate is 24.2%.
Probability of a negative pool is now only 33%. Total tests needed for 400 people = 33+(67*5)=368 tests. Only saving 8%, and adding a lot of time by retesting 2/3 of the pools. Not worth it.
OTOH, in CT where I live, test positivity is 0.8%. We could pool a whole classroom of 20 kids and still have 85% of pools be negative, saving 80% of the tests! Now, accuracy falls off with pools that large, so we wouldn’t actually, but we’d still save 72% with pools of 4.
Pooled testing is great for surveillance activities with expected low prevalence, like routinely testing asymptomatic people in schools or workplaces. I would LOVE to see this be part of safe back to school plans. But, where infections are rampant, it’s not the right strategy.
• • •
Missing some Tweet in this thread? You can try to
force a refresh
Out today in @jama_current, the 2024 update to the #NIHRECOVER 2023 #LongCOVID index. Explainer follows. 🧵 1/njamanetwork.com/journals/jama/…
We use the same methodology as in 2023 to update the index, but now include data on >3,800 more people. See this 2023 explainer for details of the methodology, not repeated here. 2/n
What’s new? Two symptoms newly contribute points: shortness of breath (2 points) and snoring/sleep apnea (1 point). (Sleep disturbance was in the original but rounded to 0 points.) 3/n
#NIHRECOVER Adult is a cohort study of ~15k adults with/without #COVID, followed prospectively. They answer symptom surveys every 3 months and do additional tests yearly. 93% of cohort has been enrolled; this paper includes 9,764 participants. recovercovid.org
Main goal of this paper is to establish an expanded, working symptom-based definition of #LongCOVID for research purposes. Please note we do not propose this as a clinical definition right now pending further validation & refinement.
Have been too busy enjoying seeing people in person and seeing so much great research at #SGIM22 to have been tweeting, but what a great meeting. @nyugrossman was out in force /1
Med student Kyle Smith had a wonderful oral presentation on how we have developed a method of finding people on oral anti psychotics who haven’t had a1c testing (no pics cause I was so busy watching!) with @SaulBlecker /2
T32 trainee Rachel Engelberg had a great poster on incarceration and health outcomes /3
Fascinating article about how research into types and efficacy of traffic stops in multiple CT communities led to changes that both reduced disparities in stops and better targeted actual public safety issues. Some examples follow:
In Newington, 40% (1,608) traffic stops were for defective lights but found only 1 DUI. Dept switched focus to moving violations (defective lights ⬇️67%, moving violations ⬆️60%). Stops with DUI arrest ⬆️250%, from 18 to 63, and disparities substantially reduced: safer & fairer!
Hamden tried increasing stops for admin issues (lights, registration) to reduce crime in Black neighborhood but rarely found contraband (7%), no effect on crime, caused huge disparities. Switched to stops for hazardous driving: crime ⬇️5%, accidents ⬇️10%, found more contraband.
A lot of chatter about hospitalization "with" versus "for" COVID, implying current hospitalization wave isn't "real." NY state is going to start trying to report the distinction; UK already does. Some thoughts, with exemplar data. /1
1st, not so easy to tell. Our health system calls "for" COVID: patients with problem list or clinical impression of respiratory failure with hypoxia (various codes), or x "due to COVID" or COVID positive is the only problem. Specific, but likely not very sensitive. /2
That is, people who meet those criteria are very likely being admitted for COVID, but others will be missed (e.g. diagnosis pneumonia, sepsis, COVID-related stroke/heart attack/PE). So, likely an underestimate. Still, if used consistently, may be useful approximation. /3
Phenomenal preprint from South Africa on #omicron severity. Insanely fast analysis with multiple linked national datasets. Kudos to the authors. Results? You'll see headlines about reduced severity, but full story more complicated. My thoughts. medrxiv.org/content/10.110…
First off, methods. They link lab tests, case data, genome data and hospital data from across all of South Africa. (Wow!) They use a proxy for omicron (SFTF) and require Ct <=30 ("real" infection).
Then they run two comparisons: omicron vs not omicron Oct-Nov, and omicron Oct-Nov vs delta Apr-Nov, and compre frequency of hospitalization and of severe disease (=hospitalised + any of ICU/O2/ventilated/ECMO/ARDS/death). Outcomes assessed on 21 Dec (day preprint posted?!).